Market Data 
Markets
Replies to post #183316 on Biotech Values
Viehbacher’s appointment in December 2008 was presented as a major cultural shift to internationalize Sanofi beyond its traditional French and European strongholds. But while the CEO’s efforts to steer the company into new areas of business has helped revive growth after Sanofi lost patents on some of its best-selling drugs, his open criticism of past research failures, and emphasis on the U.S. market has upset French labor unions and many French government officials.
AI
